Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation Results of a prospective, randomized multicenter trial
Susan C. Brozena(UCLouvain Saint-Louis Brussels), David C. Naftel(University of Alabama at Birmingham), Barry S. Clemson(OSF HealthCare), Roger M. Mills(Janssen (Belgium)), Héctor O. Ventura(Ochsner Medical Center), Robert E. Hobbs(Cleveland Clinic), Leslie W. Miller(University of Minnesota), Maria Teresa Olivari(University of Nebraska at Omaha), Robert C. Bourge(University of Alabama at Birmingham), Maryl R. Johnson(Rush University Medical Center), Rebecca Quigg(Northwestern University)
Cited by 71
Related Papers
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease
|New England Journal of Medicine|1976|480